KSCP
APFCP
SIUCP-ETS
NSCRD
SCRS
Search
- Page Path
- HOME > Search
- The Optimal Time for Urinary Catheter Removal in Enhanced Recovery After Surgery (ERAS) Protocol After Laparoscopic Rectal Cancer Surgery: When and How?
- Jaeim Lee
- Ann Coloproctol. 2021;37(4):193-194. Published online August 25, 2021
- DOI: https://doi.org/10.3393/ac.2021.00668.0095
- 10,551 View
- 133 Download
- 2 Web of Science
- 2 Citations
-
PDF -
Citations
Citations to this article as recorded by
- Predicting venous thromboembolism and determining appropriate prophylaxis in elderly patients undergoing colorectal cancer surgery with Enhanced Recovery After Surgery (ERAS) using the adjusted Caprini score
Young Sun Choi, Hyung Jin Cho, Chul Seung Lee, Dong Geun Lee, Choon Sik Chung, Gwan Cheol Lee, Dong Woo Kang, Jeong Sub Kim, Tae Gyu Kim
Annals of Coloproctology.2025; 41(4): 279. CrossRef - Perioperative outcomes of laparoscopic low anterior resection using ArtiSential® versus robotic approach in patients with rectal cancer: a propensity score matching analysis
I. K. Kim, C. S. Lee, J. H. Bae, S. R. Han, W. Alshalawi, B. C. Kim, I. K. Lee, D. S. Lee, Y. S. Lee
Techniques in Coloproctology.2024;[Epub] CrossRef
- Predicting venous thromboembolism and determining appropriate prophylaxis in elderly patients undergoing colorectal cancer surgery with Enhanced Recovery After Surgery (ERAS) using the adjusted Caprini score
- Metachronous carcinoma at the colostomy site after abdominoperineal resection of rectal cancer: a case report
- Young Sun Choi, Kil-young Lee, Youn Young Park, Hyung Jin Kim, Jaeim Lee
- Ann Coloproctol. 2023;39(2):175-177. Published online July 27, 2021
- DOI: https://doi.org/10.3393/ac.2020.00185.0026
- 5,724 View
- 174 Download
- 3 Web of Science
- 6 Citations
-
Abstract
PDF - Metachronous carcinoma at the colostomy site is very rare after abdominoperineal resection. A 53-year-old male patient underwent an abdominoperineal resection 6 years earlier for rectal cancer developed metachronous carcinoma at the site of stoma. A portion of the colon, including the stoma and the surrounding skin, was resected and a new stoma was created in the transverse colon. Although the occurrence of carcinoma at the stoma site is a rare condition, careful observation for the stoma and colonoscopy for surveillance are necessary.
-
Citations
Citations to this article as recorded by- Tumor Recurrence at the Colostomy Site: A Rare Case Report and Literature Review
Abdelhak Ettaoussi, Ilias El Azhari, Nassima Fakhiri, Abdessamad Majd, Kamal Khadija, Mounir Bouali, Abdelilah El Bakouri, Khalid Khaleq, Khalid El Hattabi
European Journal of Medical and Health Research.2025; 3(3): 215. CrossRef - A rare case of metastatic carcinoma at the colostomy site after abdominoperineal resection
Dheeraj Manne, Tirou Aroul, Robinson Smile
International Surgery Journal.2025; 12(10): 1849. CrossRef - Colostomy‐site carcinoma with primitive phenotype in a rectal cancer patient after achieving pathological complete response with neoadjuvant chemoradiotherapy
Takayuki Kodama, Maki Kanzawa, Hiroshi Hasegawa, Shuichi Tsukamoto, Mari Nishio, Manabu Shigeoka, Yu‐ichiro Koma, Tomoo Itoh, Hiroshi Yokozaki
Pathology International.2024; 74(1): 33. CrossRef - Metachronous Carcinoma at Colostomy Site Post Abdominoperineal Resection – A Rare Presentation Case Report
Muhammed Huzaifa, Ankita Singh, Vaibhav Aggarwal, Anita Dhar
Clinical Cancer Investigation Journal.2023; 12(2): 1. CrossRef - Peristomal adenocarcinoma 16 years after colorectal adenocarcinoma resection with curative intent
Kayleigh A M van Dam, Thaís T T Tweed, Bart de Vries, Henricus J Belgers
Journal of Surgical Case Reports.2023;[Epub] CrossRef - A Rare Case of Metachronous Carcinoma at the Colostomy Site Following Abdominoperineal Resection – Case Report
Naoki Todayama, Ai Hua Chang, Tomohiro Tabata
Archive of International Journal of Cancer and Allied Science.2023; 3(2): 1. CrossRef
- Tumor Recurrence at the Colostomy Site: A Rare Case Report and Literature Review
- Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer
- Yo Han Park, Jae Im Lee, Jong Kyung Park, Hang Ju Jo, Won Kyung Kang, Chang Hyeok An
- J Korean Soc Coloproctol. 2011;27(5):260-265. Published online October 31, 2011
- DOI: https://doi.org/10.3393/jksc.2011.27.5.260
- 8,803 View
- 28 Download
- 8 Citations
-
Abstract
PDF
Purpose Recent literature has shown that lymph node ratio is superior to the absolute number of metastatic lymph nodes in predicting the prognosis in several malignances other than colorectal cancer. The aim of this study was to evaluate the prognostic significance of the lymph node ratio (LNR) in patients with stage III colorectal cancer.
Methods We included 186 stage III colorectal cancer patients who underwent a curative resection over a 10-year period in one hospital. The cutoff point of LNR was chosen as 0.07 because there was significant survival difference at that LNR. The Kaplan-Meier and the Cox proportional hazard models were used to evaluate the prognostic effect according to LNR.
Results There was statistically significant longer overall survival in the group of LNR > 0.07 than in the group of LNR ≤ 7 (P = 0.008). Especially, there was a survival difference for the N1 patients group (LN < 4) according to LNR (5-year survival of N1 patients was lower in the group of LNR > 0.07, P = 0.025), but there was no survival difference for the N2 group (4 ≥ LN) according to LNR. The multivariate analysis showed that the LNR is an independent prognostic factor.
Conclusions LNR can be considered as a more accurate and potent modality for prognostic stratifications in patients with stage III colorectal cancer.
-
Citations
Citations to this article as recorded by- The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single‐institution cohort
Hongdian Zhang, Wanyi Xiao, Peng Ren, Kai Zhu, Ran Jia, Yueyang Yang, Lei Gong, Zhentao Yu, Peng Tang
Cancer Medicine.2021; 10(17): 6149. CrossRef - Lymph Node Ratio and Liver Metachronous Metastases in Colorectal Cancer
Giovanni Li Destri, Giuseppe Privitera, Gaetano La Greca, Roberto Scilletta, Antonio Pesce, Teresa Rosanna Portale, Erminia Conti, Stefano Puleo
International Surgery.2021; 105(1-3): 122. CrossRef - Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors
Gianpiero Gravante, David Hemingway, James Andrew Stephenson, David Sharpe, Ahmed Osman, Melissa Haines, Vafa Pirjamali, Roberto Sorge, Justin Ming Yeung, Michael Norwood, Andrew Miller, Kirsten Boyle
Journal of Surgical Oncology.2016; 114(5): 642. CrossRef - Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Rectal Cancer
Wafi Attaallah, Omer Gunal, Manuk Manukyan, Gulden Ozden, Cumhur Yegen
Annals of Coloproctology.2013; 29(3): 100. CrossRef - Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer
Leila Ghahramani, Leila Moaddabshoar, Samira Razzaghi, Sayed Hasan Hamedi, Saeedeh Pourahmad, Mohammad Mohammadianpanah
Annals of Colorectal Research.2013; 1(3): 81. CrossRef - Prognostic Value of Lymph Node Ratios in Node Positive Rectal Cancer Treated with Preoperative Chemoradiation
Jamal Jafari Nadoshan, Ramesh Omranipour, Omid Beiki, Kazem Zendedel, Abbas Alibakhshi, Habibollah Mahmoodzadeh
Asian Pacific Journal of Cancer Prevention.2013; 14(6): 3769. CrossRef - Proposal of a New Classification for Stage III Colorectal Cancer Based on the Number and Ratio of Metastatic Lymph Nodes
Li‐Ping Wang, Hong‐Yan Wang, Rui Cao, Cong Zhu, Xiong‐Zhi Wu
World Journal of Surgery.2013; 37(5): 1094. CrossRef - An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all
M. Medani, Niall Kelly, George Samaha, G. Duff, Vourneen Healy, Elizabeth Mulcahy, Eoghan Condon, David Waldron, Jean Saunders, J. Calvin Coffey
International Journal of Colorectal Disease.2013; 28(10): 1377. CrossRef
- The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single‐institution cohort
- Surgical Resection for Lung Metastases from Colorectal Cancer
- Hyung Jin Kim, Bong-Hyeon Kye, Jae Im Lee, Sang Chul Lee, Yoon Suk Lee, In Kyu Lee, Won Kyung Kang, Hyeon-Min Cho, Seok Whan Moon, Seong Taek Oh
- J Korean Soc Coloproctol. 2010;26(5):354-358. Published online October 31, 2010
- DOI: https://doi.org/10.3393/jksc.2010.26.5.354
- 7,310 View
- 36 Download
- 7 Citations
-
Abstract
PDF
Purpose The lung is the second most common site of metastasis from colorectal cancer. Of all patients who undergo a curative resection for colorectal cancer, 10% to 15% will develop lung metastasis. As a hepatic resection of colorectal liver metastases results in improved survival, many reports have suggested that a pulmonary resection of a colorectal lung metastasis would also improve survival. The aim of this study was to analyze the postoperative outcomes of and the prognostic factors for a surgical resection of a lung metastasis.
Methods Between August 1997 and March 2006, 27 patients underwent surgical resections for colorectal lung metastases at Seoul St. Mary's hospital. A retrospective review of patients' characteristics and various tumor factors was performed.
Results The mean interval between colorectal resection and lung metastasis was 24.0 ± 15.1 months. The overall 3- and 5-year survival rates were 76.5% and 22.2%, respectively. The mean follow-up after pulmonary resection was 39.5 ± 21.6 months (range, 3.3 to 115 months). Except for the existence of hilar-lymph-node metastasis (P < 0.001), no risk factors that we studied were statistically significant. Two patients had hilar-lymph-node metastasis. They survived for only for 3.3- and 11.6-months, respectively.
Conclusion In our study, we found that a pulmonary resection for metastases from colorectal cancer may improve survival in selected patients.
-
Citations
Citations to this article as recorded by- Prognostic factors of para-aortic lymph node metastasis from colorectal cancer in highly selected patients undergoing para-aortic lymph node dissection
Shin Emoto, Yosuke Fukunaga, Manabu Takamatsu, Hiroshi Kawachi, Shuhei Sano, Tetsuro Tominaga, Toshiki Mukai, Tomohiro Yamaguchi, Toshiya Nagasaki, Takashi Akiyoshi, Tsuyoshi Konishi, Satoshi Nagayama, Masashi Ueno
Surgery Today.2024; 54(4): 356. CrossRef - The Determinants of Long-Term Outcomes After Colorectal Cancer Surgery: A Literature Review
Olorungbami K Anifalaje, Charles Ojo, Oluwaseyi T Balogun, Fikayo A Ayodele, Abeeb Azeez, Shirley Gabriels
Cureus.2024;[Epub] CrossRef - Distant Lung Recurrence of Rectal Cancer 20 Years After Primary Surgery
Sreekanthan Gobishangar, Sivakumaran Gobinath, Antony J Thanenthiran, Subramaniyam Bakeerathan
Cureus.2023;[Epub] CrossRef - Pulmonary metastasectomy with lymphadenectomy for colorectal pulmonary metastases: A systematic review
Martijn van Dorp, Jelle Egbert Bousema, Bart Torensma, Christian Dickhoff, Frank Jozef Christiaan van den Broek, Wilhelmina Hendrika Schreurs, Michel Gonzalez, Geert Kazemier, David Jonathan Heineman
European Journal of Surgical Oncology.2022; 48(1): 253. CrossRef - Safety and efficacy of combined resection of colorectal peritoneal and liver metastases
Stephanie Downs-Canner, Yongli Shuai, Lekshmi Ramalingam, James F. Pingpank, Matthew P. Holtzman, Herbert J. Zeh, David L. Bartlett, Haroon A. Choudry
Journal of Surgical Research.2017; 219: 194. CrossRef - CT-guided percutaneous laser ablation of metastatic lung cancer: three cases report and literature review
Qiyu Zhao, Guo Tian, Fen Chen, Liyun Zhong, Tian’an Jiang
Oncotarget.2017; 8(2): 2187. CrossRef - Simultaneous Laparoscopic Resection for Synchronous Pulmonary Metastases of Colorectal Cancers
Byung-Kwon Ahn
Gastroenterology & Hepatology: Open Access.2016;[Epub] CrossRef
- Prognostic factors of para-aortic lymph node metastasis from colorectal cancer in highly selected patients undergoing para-aortic lymph node dissection
- Clinicopathological Features of Primary Jejunoileal Tumors
- Chang Hyun Kim, Bong Hyeon Kye, Jae Im Lee, Soo Hong Kim, Hyung Jin Kim, Won Kyung Kang, Seong Taek Oh
- J Korean Soc Coloproctol. 2010;26(5):334-338. Published online October 31, 2010
- DOI: https://doi.org/10.3393/jksc.2010.26.5.334
- 5,066 View
- 24 Download
- 6 Citations
-
Abstract
PDF
Purpose Tumors of the small bowel are rare, accounting for about 3-6% of all gastrointestinal neoplasms, though they cover more than 90% of the intestinal surface. However, diagnosis and treatment are difficult and present an ongoing challenge for both gastrointestinal surgeons and gastroenterologists. The aim of this study was to investigate the clinical features of small bowel tumors.
Methods Between November 1994 and November 2007, 81 patients underwent treatments for primary tumors in the jejuno-ileal region at the Department of Surgery, Kangnam St. Mary's Hospital, the Catholic University of Korea. A retrospective review of the patients' characteristics and variable tumor factors was performed.
Results The mean age of the patients was 53.2 years with 48 men and 33 women. The most common symptom was abdominal pain (59.3%), followed by bleeding (22.2%) and an abdominal mass (6.2%). We found that the patients with ileal tumors complained mainly of abdominal pain (72.9%) whereas the patients with jejunal tumors presented with gastrointestinal bleeding (36.4%) (P = 0.048). Seventy-six of the 81 patients (93.8%) had malignant tumors, including 40 (49.4%) gastrointestinal stromal tumors, 26 (32.1%) lymphomas and 5 (6.2%) adenocarcinomas. No postoperative mortalities were observed. The overall 5-year survival rate of the patients with malignant small bowel tumors was 31.8%.
Conclusion Because the clinical features of a primary tumor of the small bowel are obscure and its diagnosis is difficult, maintaining a high degree of suspicion and recognizing the possibility of a primary small bowel tumor are important.
-
Citations
Citations to this article as recorded by- Symptoms Contributing to the Diagnosis of Small Bowel Tumors
Kozo Tsuruta, Hidetoshi Takedatsu, Shinichiro Yoshioka, Masahiro Yoshikai, Kensuke Tomiyasu, Masaru Morita, Kotaro Kuwaki, Keiichi Mitsuyama, Takumi Kawaguchi
Digestion.2023; 104(6): 430. CrossRef - Clinicopathologic features, surgical treatments and outcomes of small bowel tumors
Anh Doanh Nguyen, Tu Hoang Le
Vietnam Journal of Endolaparoscopic Surgey.2022;[Epub] CrossRef - Clinicopathological Features of Small Bowel Tumors Diagnosed by Video Capsule Endoscopy and Balloon-Assisted Enteroscopy: A Single Center Experience
Ah Young Yoo, Beom Jae Lee, Won Shik Kim, Seong Min Kim, Seung Han Kim, Moon Kyung Joo, Hyo Jung Kim, Jong-Jae Park
Clinical Endoscopy.2021; 54(1): 85. CrossRef - Small Bowel Adenocarcinoma – Report of Two Cases and Review of Literature
Philip Umman, Vineeth Adiyodi, Chanchal Narayan
Indian Journal of Surgery.2013; 75(2): 123. CrossRef - Les tumeurs malignes primitives de l’intestin grêle : à propos de 11 cas
A. Farouk, A. Diffaa, R. Hafidi, F. Hlili, K. Krati
Journal Africain d'Hépato-Gastroentérologie.2012; 6(4): 284. CrossRef - A Gastrointestinal Stromal Tumor Presenting as an Emergency: a Case Report
Konstantinos Bouliaris, Aikaterini Michopoulou, Konstantinos Spanos, Vassilios Simopoulos, Ioannis Bolanis, Stylianos Germanos
Journal of Gastrointestinal Cancer.2012; 43(S1): 178. CrossRef
- Symptoms Contributing to the Diagnosis of Small Bowel Tumors
First
Prev- Page of 1
- Next
- Last
TOP
